Kineret Now Available in UK for Systemic-onset JIA and Still’s Disease
News
Kineret (anakinra), developed by Sobi, is now available as a treatment option in the United Kingdom for patients with systemic-onset juvenile idiopathic arthritis (SJIA) and adult-onset Still’s disease (AOSD). This ... Read more